Diabetes Discourse

Host: Steven Edelman, MD Guest: Kriss Halpern, JD The current state of coverage for people living with diabetes is stressed with approximately fifteen percent of all diagnosed diabetics with no health insurance, another group at risk of losing their health insurance and the last group paying exorbitant premiums to keep their insurance. How will reform affect healthcare professionals treating patie...

Host: Steven Edelman, MD Guest: Stephen Ponder, MD, CDE The emergence of type 2 diabetes in children and adolescents over the past 20 years represents a shift in pediatric chronic disease. Join host Dr. Steven Edelman and his guest, professor of pediatrics and director of the Children’s Diabetes and Endocrine Center of South Texas at Driscoll Children’s Hospital, Dr. Stephen Ponder, as they discus...

Host: Steven Edelman, MD Guest: Robert Henry, MD The ACT NOW study examined whether treatment of impaired glucose tolerance in pre-diabetic patients with pioglitazone could prevent or delay the development of type 2 diabetes. Join host Dr. Steven Edelman and his guest, endocrinologist and professor of medicine at the University of California San Diego, Dr. Robert Henry, as they discuss the results...

Host: Steven Edelman, MD Guest: Bruce Buckingham, MD The developing artificial pancreas carries tremendous potential for the treatment of diabetes. What is research telling us about the various steps to the implementation of the system? Join host Dr. Steven Edelman and his guest, pediatric endocrinologist and professor of medicine at Stanford University, Dr. Bruce Buckingham, as they discuss desig...

Host: Steven Edelman, MD Guest: Richard Bergenstal, MD The ACCORD, ADVANCE and VA Diabetes Trials seem to indicate that there is no real benefit of intensive glycemic control on cardiovascular events in patients with type 2 diabetes. Join host Dr. Steven Edelman and his guest, executive director of the International Diabetes Center at Park Nicollet, Dr. Richard Bergenstal, as they discuss the impl...

Host: Steven Edelman, MD Guest: Anne-Marie Felton World Diabetes Day marks the annual global awareness campaign for diabetes by the International Diabetes Federation. The campaign’s theme of "diabetes education and prevention" is scheduled for five years. How will the IDF implement this broad campaign for both the health care professionals and people living with diabetes? Join host Dr. Steven Edel...

Host: Steven Edelman, MD Guest: Joseph Ma, PharmD Pharmacogenomics is applied to select medications with the goal of optimizing drug therapy: maximizing efficacy, minimizing toxicity, and minimizing pharmacokinetic and pharmacodynamic variability. Join guest host, Dr. Candis Morello and Dr. Joseph Ma, assistant professor of clinical pharmacy at the University of San Diego Skaggs School of Pharmacy...

Host: Steven Edelman, MD Guest: Lisa Kroon, PharmD, CD The new class of medications known as dipeptidyl peptidase-4 (DPP-4) inhibitors, which stimulate the pancreas to make more insulin after eating a meal, may be changing the way we treat people with type 2 diabetes. Join guest host, Dr. Candis Morello and her guest, professor of clinical pharmacy in the School of Pharmacy at the University of Ca...

Host: Steven Edelman, MD Guest: Sandra Bourdette The results of the landmark Diabetes Control and Complications Trial proved that intensive management of diabetes can significantly improve diabetes outcomes. The education of both the healthcare professional and patient is a key component in the successful management of diabetes. Join host Dr. Steven Edelman and his guest, executive director of Tak...

Host: Candis Morello, PharmD, CDE Guest: Sarah Lorentz, PharmD Why are people living with diabetes more likely to die with flu and pneumonia? During flu epidemics, this risk is particularly high when additional risk factors present such as cardiovascular disease and kidney disease. Join guest host Dr. Candis Morello and her guest, pharmacist specializing in ambulatory care, Dr. Sarah Lorentz, as t...

Host: Candis Morello, PharmD, CDE Guest: Brookie Best, PharmD New drug delivery technologies are changing one of the key therapeutic challenges of insulin delivery in the management of diabetes. Join guest host Dr. Candis Morello and her guest, Dr. Brookie Best, assistant clinical professor of pharmacy and pediatrics at University of California San Diego, as they discuss the emerging new technolog...

Host: Steven Edelman, MD Guest: Daniel Einhorn, MD The new American Association of Clinical Endocrinologists (AACE) guidelines represent a major shift in the way type 2 diabetes is treated. An emphasis on hypoglycemia, adherence to therapy and new medications are included in this new algorithm. Join host Dr. Steven Edelman and his guest, president-elect of AACE, Dr. Daniel Einhorn, as they discuss...

Host: Steven Edelman, MD Guest: David Ward, MD Diabetes is the most common cause of kidney failure. However, most people with diabetes can avoid end-stage kidney disease and minimize their risk of kidney failure with intensive management of diabetes. Join host Dr. Steven Edelman and his guest, nephrologist and professor of medicine at the University of California San Diego, Dr. David Ward as they...

Host: Steven Edelman, MD Guest: Irl Hirsch, MD, MACP Lowering blood sugar levels in critically ill patients is a widely embraced practice. But according to the results of the NICE-SUGAR study, lowering blood glucose levels in ICU patients may not be safe. Join host Dr. Steven Edelman and his guest, Dr. Irl Hirsch, professor of medicine and the Diabetes Treatment and Teaching chair at the Universit...

Host: Steven Edelman, MD Guest: Thomas Moore, MD Characterized by high blood sugar levels first recognized during pregnancy, gestational diabetes affects about four percent of all pregnant women. Join host Dr. Steven Edelman and Dr. Thomas Moore, director of perinatal medicine at University of California, San Diego Medical Center, as they discuss the diagnosis and treatment for gestational diabete...

Host: Steven Edelman, MD Guest: Lorena Drago, MS, RD, CDN, CDE According to a recent study, people with type 2 diabetes are not meeting important nutritional recommendations. Finding the correct balance of carbohydrates, protein and fat along with portion control and moderation is a challenge. Our guest, dietitian and certified diabetes educator, Lorena Drago, discusses the variance in recommended...

Host: Steven Edelman, MD Guest: Vivian Fonseca, MD, FRCP SGLT2 is responsible for glucose re-absorption in the kidney and decreasing SGLT2 function promotes glucose excretion to help reduce blood sugar levels, making it an attractive area for the treatment of diabetes. Join host Dr. Steven Edelman and his guest, professor of medicine at Tulane University, Dr. Vivian Fonseca, as they discuss the ne...

Host: Steven Edelman, MD Guest: Ralph A. DeFronzo, MD Insulin resistance in muscle, liver and ß-cell represent the core pathophysiologic defects in type 2 diabetes. In addition, the ominous octet all play important roles in the development of glucose intolerance in people with type 2 diabetes. How will this new paradigm shift our understanding in the way we treat our type 2 patients? Dr. Ralph DeF...

Host: Steven Edelman, MD Guest: John Buse, MD, PhD Diabetes therapeutics such as glucose and weight control are major physiological functions of the new glucagon-like peptide-1 (GLP-1) agonists. But is there evidence to suggest that GLP-1 may also have some cardiovascular benefits? Join host Dr. Steven Edelman and Dr. John Buse, professor of medicine at the University of North Carolina at Chapel H...

Host: Steven Edelman, MD Guest: Kelly Close, MBA The prevalence of diabetes complications and its associated costs represent an infrastructure that may be virtually unsustainable in the near future. Join host Dr. Steven Edelman and his guest, editor-in-chief of the diabetes publications Closer Look and Diabetes Close Up , Kelly Close, as they discuss the challenges of both regulation and reimburse...

Host: Steven Edelman, MD Guest: Robert Henry, MD The physiological effects of glucagon-like peptide-1 (GLP-1) are exciting because of the potential clinical relevance in treating two of the major abnormalities that contribute to type 2 diabetes: impaired insulin secretion and excessive glucagon secretion. GLP-1 also appears to have effects on gastric emptying and appetite suppression. Join host Dr...

Host: Steven Edelman, MD Guest: Daniel Blanchard, MD Diabetes is strongly linked with a number of risk factors for coronary problems such as high blood pressure, high cholesterol, abdominal obesity that significantly increases the risk of heart attack and stroke. Recent studies indicate that new drug-eluting stents are a reasonable option for the diabetic population who do not want bypass or that...

Host: Steven Edelman, MD Guest: Patrick J. Boyle, MD The frequency of hypoglycemic events for both type 1 and type 2 diabetics increases due to tight blood glucose control and more intensive treatment schedules. The disease differs significantly between type 1 and type 2 in the body’s defense mechanism of decreasing insulin concentration. Join host Dr. Steven Edelman and his guest, endocrinologist...

Host: Steven Edelman, MD Guest: Ingrid Kruse, DPM Diabetic peripheral neuropathy remains one of the most common complications in diabetes. Because type 2 diabetes often goes undiagnosed for many years, it is common for patients to present with some degree of neuropathy. Our guest, podiatrist, specializing in diabetic foot problems, Dr. Ingrid Kruse, discusses the variance in both symptoms and trea...

Host: Steven Edelman, MD Guest: Candis Morello, PharmD, CDE Dietary supplements and alternatives medicines are on the rise, however effectiveness of most of these products has not been demonstrated. Supplements differ significantly over prescription drugs in both production and regulation. How do healthcare professionals stay ahead of this rapidly growing area? Join host Dr. Steven Edelman and his...